Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Human Wharton's jelly stem cell conditioned medium enhances freeze-thaw survival and expansion of cryopreserved CD34+ cells.

Lin HD, Bongso A, Gauthaman K, Biswas A, Choolani M, Fong CY.

Stem Cell Rev. 2013 Apr;9(2):172-83. doi: 10.1007/s12015-013-9426-7.

PMID:
23314930
2.

Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo.

Fong CY, Gauthaman K, Cheyyatraivendran S, Lin HD, Biswas A, Bongso A.

J Cell Biochem. 2012 Feb;113(2):658-68. doi: 10.1002/jcb.23395.

PMID:
21976004
3.

Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.

Fong CY, Subramanian A, Biswas A, Bongso A.

J Cell Biochem. 2016 Apr;117(4):815-27. doi: 10.1002/jcb.25375. Epub 2015 Sep 17.

PMID:
26365815
4.

Conditioned Medium from Placental Mesenchymal Stem Cells Reduces Oxidative Stress during the Cryopreservation of Ex Vivo Expanded Umbilical Cord Blood Cells.

Kadekar D, Rangole S, Kale V, Limaye L.

PLoS One. 2016 Oct 25;11(10):e0165466. doi: 10.1371/journal.pone.0165466. eCollection 2016.

5.

ROCK inhibitor Y-27632 increases thaw-survival rates and preserves stemness and differentiation potential of human Wharton's jelly stem cells after cryopreservation.

Gauthaman K, Fong CY, Subramanian A, Biswas A, Bongso A.

Stem Cell Rev. 2010 Dec;6(4):665-76. doi: 10.1007/s12015-010-9184-8.

PMID:
20711690
6.

Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells.

Fong CY, Subramanian A, Biswas A, Gauthaman K, Srikanth P, Hande MP, Bongso A.

Reprod Biomed Online. 2010 Sep;21(3):391-401. doi: 10.1016/j.rbmo.2010.04.010. Epub 2010 Apr 24.

PMID:
20638335
7.

Human Wharton's jelly stem cell conditioned medium and cell-free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice.

Gauthaman K, Fong CY, Arularasu S, Subramanian A, Biswas A, Choolani M, Bongso A.

J Cell Biochem. 2013 Feb;114(2):366-77. doi: 10.1002/jcb.24367.

PMID:
22930595
8.

Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells.

Madkaikar M, Ghosh K, Gupta M, Swaminathan S, Mohanty D.

Acta Haematol. 2007;118(3):153-9. Epub 2007 Sep 20.

PMID:
17890847
9.

Cryopreservation of cord blood after liquid storage.

Hubel A, Carlquist D, Clay M, McCullough J.

Cytotherapy. 2003;5(5):370-6.

PMID:
14578099
10.

The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord.

Bongso A, Fong CY.

Stem Cell Rev. 2013 Apr;9(2):226-40. doi: 10.1007/s12015-012-9418-z. Review.

PMID:
23233233
11.

Direct immunomagnetic method for CD34+ cell selection from cryopreserved cord blood grafts for ex vivo expansion protocols.

Querol S, Capmany G, Azqueta C, Gabarró M, Fornas O, Martín-Henao GA, García J.

Transfusion. 2000 Jun;40(6):625-31.

PMID:
10864979
12.

The effect of freezing on the recovery and expansion of umbilical cord blood hematopoietic stem cells.

Beshlawy AE, Metwally HG, Khalek KA, Hammoud RF, Mousa SM.

Exp Clin Transplant. 2009 Mar;7(1):50-5.

13.

Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.

Meyer TP, Hofmann B, Zaisserer J, Jacobs VR, Fuchs B, Rapp S, Weinauer F, Burkhart J.

Cytotherapy. 2006;8(3):265-76.

PMID:
16793735
14.

Ex vivo expansion of hematopoietic stem- and progenitor cells from cord blood in coculture with mesenchymal stroma cells from amnion, chorion, Wharton's jelly, amniotic fluid, cord blood, and bone marrow.

Klein C, Strobel J, Zingsem J, Richter RH, Goecke TW, Beckmann MW, Eckstein R, Weisbach V.

Tissue Eng Part A. 2013 Dec;19(23-24):2577-85. doi: 10.1089/ten.tea.2013.0073.

PMID:
24308543
15.

Novel cryoprotectant significantly improves the post-thaw recovery and quality of HSC from CB.

Stylianou J, Vowels M, Hadfield K.

Cytotherapy. 2006;8(1):57-61.

PMID:
16627345
16.

Polyunsaturated fatty acids confer cryoresistance on megakaryocytes generated from cord blood and also enhance megakaryocyte production from cryopreserved cord blood cells.

Shabrani NC, Khan NF, Kale VP, Limaye LS.

Cytotherapy. 2012 Mar;14(3):366-80. doi: 10.3109/14653249.2011.649186. Epub 2012 Jan 17.

PMID:
22250991
17.

Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.

Jang YK, Jung DH, Jung MH, Kim DH, Yoo KH, Sung KW, Koo HH, Oh W, Yang YS, Yang SE.

Ann Hematol. 2006 Apr;85(4):212-25. Epub 2006 Jan 4. Erratum in: Ann Hematol. 2006 May;85(5):343-4.

PMID:
16391912
18.

The comparison of different protocols for expansion of umbilical-cord blood hematopoietic stem cells.

Chivu M, Diaconu CC, Bleotu C, Alexiu I, Brasoveanu L, Cernescu C.

J Cell Mol Med. 2004 Apr-Jun;8(2):223-31.

19.

Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer.

Minegishi M, Itoh T, Fukawa N, Kitaura T, Miura J, Takahashi H, Suzuki A, Kudo Y, Narita A, Sato Y, Suzuki M, Watanabe T, Wada Y, Takeyama Y, Tsuchiya S.

Int J Hematol. 2007 Jan;85(1):78-84.

PMID:
17261506
20.

Ex vivo expansion and clonality of CD34+ selected cells from bone marrow and cord blood in a serum-free media.

Kim SK, Koh SK, Song SU, Shin SH, Choi GS, Kim WC, Lee MH, Seoh JY, Park SK, Fraser JK.

Mol Cells. 2002 Dec 31;14(3):367-73.

Supplemental Content

Support Center